{"entity":{"type":"insider","cik":"0001627183","url":"/insider/0001627183","json_url":"/insider/0001627183.json","name":"O'Brien Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":11,"first":"2019-01-18","last":"2026-01-05","span_basis":"filed_date"},"name_variants":[{"name":"O'Brien Patrick","source":"filing","n_filings":11,"first_seen":"2019-01-18","last_seen":"2026-01-05"}],"transactions":[{"id":6094581,"accession":"0001627183-26-000001","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-17","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13451.0,"shares_display":"13,451","price_per_share":62.96,"price_display":"62.96","price_state":"stated","total_value":846874.96,"total_display":"846,874.96","shares_owned_after":500418.0,"shares_owned_after_display":"500,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094578,"accession":"0001627183-26-000001","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-16","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11842.0,"shares_display":"11,842","price_per_share":63.84,"price_display":"63.84","price_state":"stated","total_value":755993.28,"total_display":"755,993.28","shares_owned_after":488576.0,"shares_owned_after_display":"488,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094576,"accession":"0001627183-26-000001","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-15","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6164.0,"shares_display":"6,164","price_per_share":62.23,"price_display":"62.23","price_state":"stated","total_value":383585.72,"total_display":"383,585.72","shares_owned_after":513869.0,"shares_owned_after_display":"513,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094573,"accession":"0001627183-26-000001","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-14","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5873.0,"shares_display":"5,873","price_per_share":62.91,"price_display":"62.91","price_state":"stated","total_value":369470.43,"total_display":"369,470.43","shares_owned_after":477290.0,"shares_owned_after_display":"477,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094571,"accession":"0001627183-26-000001","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-13","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4368.0,"shares_display":"4,368","price_per_share":61.2,"price_display":"61.20","price_state":"stated","total_value":267321.6,"total_display":"267,321.60","shares_owned_after":520033.0,"shares_owned_after_display":"520,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094568,"accession":"0001627183-26-000001","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-12","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":64.44,"price_display":"64.44","price_state":"stated","total_value":173988.0,"total_display":"173,988.00","shares_owned_after":485876.0,"shares_owned_after_display":"485,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094566,"accession":"0001627183-26-000001","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-11","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2336.0,"shares_display":"2,336","price_per_share":64.04,"price_display":"64.04","price_state":"stated","total_value":149597.44,"total_display":"149,597.44","shares_owned_after":474954.0,"shares_owned_after_display":"474,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094563,"accession":"0001627183-26-000001","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-10","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":66.01,"price_display":"66.01","price_state":"stated","total_value":59409.0,"total_display":"59,409.00","shares_owned_after":484976.0,"shares_owned_after_display":"484,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094561,"accession":"0001627183-26-000001","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-9","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":62.25,"price_display":"62.25","price_state":"stated","total_value":56025.0,"total_display":"56,025.00","shares_owned_after":483163.0,"shares_owned_after_display":"483,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094559,"accession":"0001627183-26-000001","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-8","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":61.12,"price_display":"61.12","price_state":"stated","total_value":36672.0,"total_display":"36,672.00","shares_owned_after":484063.0,"shares_owned_after_display":"484,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094558,"accession":"0001627183-26-000001","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-7","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":313.0,"shares_display":"313","price_per_share":68.0,"price_display":"68.00","price_state":"stated","total_value":21284.0,"total_display":"21,284.00","shares_owned_after":484663.0,"shares_owned_after_display":"484,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":6094556,"accession":"0001627183-26-000001","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001627183-26-000001","line_url":"/filing/0001627183-26-000001#line-6","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO)","officer_title":"COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46.0,"shares_display":"46","price_per_share":68.0,"price_display":"68.00","price_state":"stated","total_value":3128.0,"total_display":"3,128.00","shares_owned_after":474908.0,"shares_owned_after_display":"474,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"},{"id":4896649,"accession":"0001628280-25-000806","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-25-000806","line_url":"/filing/0001628280-25-000806#line-4","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":19.69,"price_display":"19.69","price_state":"stated","total_value":157520.0,"total_display":"157,520.00","shares_owned_after":527201.0,"shares_owned_after_display":"527,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-07","scope":"insider"},{"id":4896646,"accession":"0001628280-25-000806","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-000806","line_url":"/filing/0001628280-25-000806#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19658.0,"shares_display":"19,658","price_per_share":19.69,"price_display":"19.69","price_state":"stated","total_value":387066.02,"total_display":"387,066.02","shares_owned_after":544727.0,"shares_owned_after_display":"544,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":4896641,"accession":"0001628280-25-000806","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-000806","line_url":"/filing/0001628280-25-000806#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9526.0,"shares_display":"9,526","price_per_share":20.1,"price_display":"20.10","price_state":"stated","total_value":191472.6,"total_display":"191,472.60","shares_owned_after":535201.0,"shares_owned_after_display":"535,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":2048251,"accession":"0001628280-24-000744","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001628280-24-000744","line_url":"/filing/0001628280-24-000744#line-9","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12741.0,"shares_display":"12,741","price_per_share":35.65,"price_display":"35.65","price_state":"stated","total_value":454216.65,"total_display":"454,216.65","shares_owned_after":464385.0,"shares_owned_after_display":"464,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-05","scope":"insider"},{"id":2048250,"accession":"0001628280-24-000744","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001628280-24-000744","line_url":"/filing/0001628280-24-000744#line-8","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8200.0,"shares_display":"8,200","price_per_share":34.99,"price_display":"34.99","price_state":"stated","total_value":286918.0,"total_display":"286,918.00","shares_owned_after":477126.0,"shares_owned_after_display":"477,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-05","scope":"insider"},{"id":2048249,"accession":"0001628280-24-000744","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001628280-24-000744","line_url":"/filing/0001628280-24-000744#line-7","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":33.99,"price_display":"33.99","price_state":"stated","total_value":64581.0,"total_display":"64,581.00","shares_owned_after":485326.0,"shares_owned_after_display":"485,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-05","scope":"insider"},{"id":2048248,"accession":"0001628280-24-000744","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001628280-24-000744","line_url":"/filing/0001628280-24-000744#line-6","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":32.63,"price_display":"32.63","price_state":"stated","total_value":52208.0,"total_display":"52,208.00","shares_owned_after":402226.0,"shares_owned_after_display":"402,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":2048244,"accession":"0001628280-24-000744","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-24-000744","line_url":"/filing/0001628280-24-000744#line-4","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3849.0,"shares_display":"3,849","price_per_share":31.83,"price_display":"31.83","price_state":"stated","total_value":122513.67,"total_display":"122,513.67","shares_owned_after":408726.0,"shares_owned_after_display":"408,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":2048242,"accession":"0001628280-24-000744","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-24-000744","line_url":"/filing/0001628280-24-000744#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":32.52,"price_display":"32.52","price_state":"stated","total_value":91056.0,"total_display":"91,056.00","shares_owned_after":405926.0,"shares_owned_after_display":"405,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":2048241,"accession":"0001628280-24-000744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-000744","line_url":"/filing/0001628280-24-000744#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":32.65,"price_display":"32.65","price_state":"stated","total_value":55505.0,"total_display":"55,505.00","shares_owned_after":403826.0,"shares_owned_after_display":"403,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":2048238,"accession":"0001628280-24-000744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-000744","line_url":"/filing/0001628280-24-000744#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":33.41,"price_display":"33.41","price_state":"stated","total_value":13364.0,"total_display":"13,364.00","shares_owned_after":405526.0,"shares_owned_after_display":"405,526","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":8390564,"accession":"0001209191-23-002481","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002481","line_url":"/filing/0001209191-23-002481#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":37.39,"price_display":"37.39","price_state":"stated","total_value":280425.0,"total_display":"280,425.00","shares_owned_after":420875.0,"shares_owned_after_display":"420,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-06","scope":"insider"},{"id":8390559,"accession":"0001209191-23-002481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002481","line_url":"/filing/0001209191-23-002481#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":37.39,"price_display":"37.39","price_state":"stated","total_value":280425.0,"total_display":"280,425.00","shares_owned_after":413375.0,"shares_owned_after_display":"413,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-06","scope":"insider"},{"id":8677136,"accession":"0001209191-23-002114","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-23-002114","line_url":"/filing/0001209191-23-002114#line-8","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5527.0,"shares_display":"5,527","price_per_share":38.54,"price_display":"38.54","price_state":"stated","total_value":213010.58,"total_display":"213,010.58","shares_owned_after":372695.0,"shares_owned_after_display":"372,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":8677134,"accession":"0001209191-23-002114","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-002114","line_url":"/filing/0001209191-23-002114#line-7","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5286.0,"shares_display":"5,286","price_per_share":38.58,"price_display":"38.58","price_state":"stated","total_value":203933.88,"total_display":"203,933.88","shares_owned_after":363945.0,"shares_owned_after_display":"363,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":8677131,"accession":"0001209191-23-002114","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-23-002114","line_url":"/filing/0001209191-23-002114#line-6","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2894.0,"shares_display":"2,894","price_per_share":37.58,"price_display":"37.58","price_state":"stated","total_value":108756.52,"total_display":"108,756.52","shares_owned_after":369231.0,"shares_owned_after_display":"369,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":8677129,"accession":"0001209191-23-002114","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-002114","line_url":"/filing/0001209191-23-002114#line-5","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2653.0,"shares_display":"2,653","price_per_share":37.53,"price_display":"37.53","price_state":"stated","total_value":99567.09,"total_display":"99,567.09","shares_owned_after":378222.0,"shares_owned_after_display":"378,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":8677126,"accession":"0001209191-23-002114","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-002114","line_url":"/filing/0001209191-23-002114#line-4","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":39.74,"price_display":"39.74","price_state":"stated","total_value":19870.0,"total_display":"19,870.00","shares_owned_after":372195.0,"shares_owned_after_display":"372,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":8677123,"accession":"0001209191-23-002114","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-002114","line_url":"/filing/0001209191-23-002114#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":39.55,"price_display":"39.55","price_state":"stated","total_value":11865.0,"total_display":"11,865.00","shares_owned_after":363645.0,"shares_owned_after_display":"363,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":8677120,"accession":"0001209191-23-002114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002114","line_url":"/filing/0001209191-23-002114#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":270.0,"shares_display":"270","price_per_share":40.53,"price_display":"40.53","price_state":"stated","total_value":10943.1,"total_display":"10,943.10","shares_owned_after":363375.0,"shares_owned_after_display":"363,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":8677116,"accession":"0001209191-23-002114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002114","line_url":"/filing/0001209191-23-002114#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (COO and General Counsel)","officer_title":"COO and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70.0,"shares_display":"70","price_per_share":40.8,"price_display":"40.80","price_state":"stated","total_value":2856.0,"total_display":"2,856.00","shares_owned_after":372125.0,"shares_owned_after_display":"372,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":6622379,"accession":"0001209191-22-002599","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-002599","line_url":"/filing/0001209191-22-002599#line-6","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12434.0,"shares_display":"12,434","price_per_share":60.49,"price_display":"60.49","price_state":"stated","total_value":752132.66,"total_display":"752,132.66","shares_owned_after":368941.0,"shares_owned_after_display":"368,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":6622377,"accession":"0001209191-22-002599","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-002599","line_url":"/filing/0001209191-22-002599#line-5","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10350.0,"shares_display":"10,350","price_per_share":61.88,"price_display":"61.88","price_state":"stated","total_value":640458.0,"total_display":"640,458.00","shares_owned_after":358591.0,"shares_owned_after_display":"358,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":6622374,"accession":"0001209191-22-002599","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-002599","line_url":"/filing/0001209191-22-002599#line-4","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":62.49,"price_display":"62.49","price_state":"stated","total_value":312450.0,"total_display":"312,450.00","shares_owned_after":353591.0,"shares_owned_after_display":"353,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":6622370,"accession":"0001209191-22-002599","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-002599","line_url":"/filing/0001209191-22-002599#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":63.75,"price_display":"63.75","price_state":"stated","total_value":280500.0,"total_display":"280,500.00","shares_owned_after":349191.0,"shares_owned_after_display":"349,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":6622367,"accession":"0001209191-22-002599","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-002599","line_url":"/filing/0001209191-22-002599#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":316.0,"shares_display":"316","price_per_share":64.35,"price_display":"64.35","price_state":"stated","total_value":20334.6,"total_display":"20,334.60","shares_owned_after":348875.0,"shares_owned_after_display":"348,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-07","scope":"insider"},{"id":4924834,"accession":"0001209191-21-009368","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-009368","line_url":"/filing/0001209191-21-009368#line-5","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45348.0,"shares_display":"45,348","price_per_share":88.88,"price_display":"88.88","price_state":"stated","total_value":4030530.24,"total_display":"4,030,530.24","shares_owned_after":298811.0,"shares_owned_after_display":"298,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":4924830,"accession":"0001209191-21-009368","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009368","line_url":"/filing/0001209191-21-009368#line-4","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31255.0,"shares_display":"31,255","price_per_share":88.08,"price_display":"88.08","price_state":"stated","total_value":2752940.4,"total_display":"2,752,940.40","shares_owned_after":344159.0,"shares_owned_after_display":"344,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":4924827,"accession":"0001209191-21-009368","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-009368","line_url":"/filing/0001209191-21-009368#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7961.0,"shares_display":"7,961","price_per_share":86.72,"price_display":"86.72","price_state":"stated","total_value":690377.92,"total_display":"690,377.92","shares_owned_after":375414.0,"shares_owned_after_display":"375,414","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":4924822,"accession":"0001209191-21-009368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-009368","line_url":"/filing/0001209191-21-009368#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5436.0,"shares_display":"5,436","price_per_share":89.66,"price_display":"89.66","price_state":"stated","total_value":487391.76,"total_display":"487,391.76","shares_owned_after":293375.0,"shares_owned_after_display":"293,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5242881,"accession":"0001209191-21-002583","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-002583","line_url":"/filing/0001209191-21-002583#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13243.0,"shares_display":"13,243","price_per_share":72.67,"price_display":"72.67","price_state":"stated","total_value":962368.81,"total_display":"962,368.81","shares_owned_after":293375.0,"shares_owned_after_display":"293,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-07","scope":"insider"},{"id":5242879,"accession":"0001209191-21-002583","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-002583","line_url":"/filing/0001209191-21-002583#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10615.0,"shares_display":"10,615","price_per_share":72.27,"price_display":"72.27","price_state":"stated","total_value":767146.05,"total_display":"767,146.05","shares_owned_after":306618.0,"shares_owned_after_display":"306,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-07","scope":"insider"},{"id":5242875,"accession":"0001209191-21-002583","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-002583","line_url":"/filing/0001209191-21-002583#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1142.0,"shares_display":"1,142","price_per_share":70.78,"price_display":"70.78","price_state":"stated","total_value":80830.76,"total_display":"80,830.76","shares_owned_after":317233.0,"shares_owned_after_display":"317,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-06","filed_date":"2021-01-07","scope":"insider"},{"id":2709665,"accession":"0001209191-20-002615","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-002615","line_url":"/filing/0001209191-20-002615#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8931.0,"shares_display":"8,931","price_per_share":60.43,"price_display":"60.43","price_state":"stated","total_value":539700.33,"total_display":"539,700.33","shares_owned_after":258475.0,"shares_owned_after_display":"258,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-08","scope":"insider"},{"id":2709662,"accession":"0001209191-20-002615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-002615","line_url":"/filing/0001209191-20-002615#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5594.0,"shares_display":"5,594","price_per_share":59.61,"price_display":"59.61","price_state":"stated","total_value":333458.34,"total_display":"333,458.34","shares_owned_after":267406.0,"shares_owned_after_display":"267,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-08","scope":"insider"},{"id":2709657,"accession":"0001209191-20-002615","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002615","line_url":"/filing/0001209191-20-002615#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":61.02,"price_display":"61.02","price_state":"stated","total_value":6102.0,"total_display":"6,102.00","shares_owned_after":258375.0,"shares_owned_after_display":"258,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-08","scope":"insider"},{"id":8694432,"accession":"0001209191-19-033296","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-033296","line_url":"/filing/0001209191-19-033296#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":24.88,"price_display":"24.88","price_state":"stated","total_value":746400.0,"total_display":"746,400.00","shares_owned_after":203000.0,"shares_owned_after_display":"203,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-28","filed_date":"2019-05-29","scope":"insider"},{"id":8526091,"accession":"0001209191-19-004629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-004629","line_url":"/filing/0001209191-19-004629#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001627183","owner_name":"O'Brien Patrick","owner_url":"/insider/0001627183","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72000.0,"shares_display":"72,000","price_per_share":14.43,"price_display":"14.43","price_state":"stated","total_value":1038960.0,"total_display":"1,038,960.00","shares_owned_after":233000.0,"shares_owned_after_display":"233,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-18","filed_date":"2019-01-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":50,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":50,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":50},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","url":"/issuer/0000879407","role":"Officer (COO)","n_filings":11,"first_seen":"2019-01-18","last_seen":"2026-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001627183","retrieved_at":"2026-08-21T02:48:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}